- Trials with a EudraCT protocol (10)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
10 result(s) found for: Ion Channel.
Displaying page 1 of 1.
EudraCT Number: 2009-011291-29 | Sponsor Protocol Number: RACE 3 | Start Date*: 2011-08-16 | |||||||||||
Sponsor Name:Interuniversity Cardiology Institute of the Netherlands (ICIN) | |||||||||||||
Full Title: Routine versus Aggressive Upstream Rhythm Control for Prevention of Early Atrial Fibrillation in Heart Failure: RACE 3 | |||||||||||||
Medical condition: atrial fibrillation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002438-34 | Sponsor Protocol Number: FAM1 | Start Date*: 2020-08-19 | |||||||||||
Sponsor Name:Department of Neurology, Odense University Hospital | |||||||||||||
Full Title: Fampridine for treatment of residual neurological deficits in patients treated with immunoglobulins for chronic inflammatory demyelinating polyneuropathy | |||||||||||||
Medical condition: Chronic inflammatory demyelinating polyneuropathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002837-31 | Sponsor Protocol Number: GLPG2222-CL-201 | Start Date*: 2016-12-02 | |||||||||||
Sponsor Name:Galapagos NV | |||||||||||||
Full Title: A phase IIa, randomized, double-blind, placebo-controlled study to evaluate GLPG2222 in ivacaftor-treated subjects with Cystic Fibrosis harbouring one F508del CFTR mutation and a second gating (cla... | |||||||||||||
Medical condition: Cystic Fibrosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) GB (Completed) DE (Completed) BE (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-002752-34 | Sponsor Protocol Number: Clin-AGI003-001 | Start Date*: 2004-12-20 | |||||||||||
Sponsor Name:AGI Therapeutics Limited | |||||||||||||
Full Title: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF AGI 003 IN THE TREATMENT OF NON-CONSTIPATION PREDOMINANT IRRITABLE BOWEL SYNDROME. | |||||||||||||
Medical condition: Irritable bowel syndrome (not constipation predominant). | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: LT (Completed) GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003292-30 | Sponsor Protocol Number: GLPG1837-CL-202 | Start Date*: 2016-01-18 | |||||||||||
Sponsor Name:Galapagos NV | |||||||||||||
Full Title: A phase IIa, open-label study of two doses of GLPG1837 in subjects with cystic fibrosis and the S1251N mutation. | |||||||||||||
Medical condition: Cystic fibrosis with the S1251N mutation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003291-77 | Sponsor Protocol Number: GLPG1837-CL-201 | Start Date*: 2016-02-02 | |||||||||||
Sponsor Name:Galapagos NV | |||||||||||||
Full Title: A phase IIa, open label study of multiple doses of GLPG1837 in subjects with cystic fibrosis and the G551D mutation | |||||||||||||
Medical condition: Cystic fibrosis with the G551D mutation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) CZ (Completed) IE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-003774-27 | Sponsor Protocol Number: BC-180-12 | Start Date*: 2014-01-20 |
Sponsor Name:AlgiPharma AS | ||
Full Title: An open label, randomised, two-way crossover scintigraphic study to investigate lung deposition of radiolabelled OligoG delivered as a dry powder and as a nebulised solution in cystic fibrosis pati... | ||
Medical condition: Cystic fibrosis (CF) is an autosomal, recessive inheritable disease caused by a homozygote defect at the long arm of Chromosome 7. This mutation causes absence or defect of the cystic fibrosis tran... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-000724-40 | Sponsor Protocol Number: PTC124-GD-006-CF | Start Date*: 2007-09-27 | |||||||||||
Sponsor Name:PTC Therapeutics, Inc. | |||||||||||||
Full Title: A Phase 2 Study of PTC124 as an Oral Treatment for Nonsense-Mutation-Mediated Cystic Fibrosis | |||||||||||||
Medical condition: Cystic Fibrosis | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-002181-42 | Sponsor Protocol Number: GLPG2737-CL-202 | Start Date*: 2017-10-27 | |||||||||||
Sponsor Name:Galapagos NV | |||||||||||||
Full Title: A Phase IIa, randomized, double-blind, placebo-controlled study to evaluate GLPG2737 in Orkambi-treated subjects with cystic fibrosis homozygous for the F508del mutation | |||||||||||||
Medical condition: Cystic fibrosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000098-61 | Sponsor Protocol Number: GLPG3067-CL-202 | Start Date*: 2018-06-22 | |||||||||||
Sponsor Name:Galapagos NV | |||||||||||||
Full Title: A Phase II, randomized, double-blind, placebo-controlled, multi-center study to evaluate the efficacy, safety, tolerability and pharmacokinetics of orally administered combination of GLPG3067, GLPG... | |||||||||||||
Medical condition: Cystic Fibrosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.